Hematologist — Blood Disease and Cancer Specialist

A hematologist is a physician who has undertaken advanced postgraduate training in internal medicine or paediatrics, followed by subspecialty fellowship training in haematology. These specialists possess detailed clinical expertise in the physiology and pathology of cellular blood elements (erythrocytes, leukocytes, and platelets), coagulation cascades, haemoglobin structure, and haematopoietic organs like the spleen, lymph nodes, and bone marrow.

In cancer medicine, the field frequently merges with oncology to form hematology-oncology. A hematologist-oncologist evaluates complex diagnostic findings—such as flow cytometry, cytogenetics, and molecular assays—to formulate comprehensive systemic treatment plans. They coordinate multimodal therapeutic strategies including cytotoxic chemotherapy, targeted biological therapies, immunotherapies, and cellular therapies such as allogeneic stem cell transplantation or chimeric antigen receptor (CAR) T-cell therapy.

Having a hematologist on your multidisciplinary team is critical when dealing with blood cancers or treatment-related blood abnormalities. Blood malignancies require distinct diagnostic evaluations, genetic analyses, and systemic treatment approaches compared to solid organ tumours. A hematologist interprets intricate marrow biopsies and chromosomal findings to recommend personalised therapies. Furthermore, they expertly manage supportive care needs—such as prescribing growth factors, overseeing blood transfusions, and treating venous thromboembolism—ensuring that cancer therapies can proceed safely with minimal toxicity, bleeding risk, and procedural complications.

Hematologists utilise specialised diagnostic tools to investigate blood disorders. Evaluations begin with complete blood counts and microscopic peripheral blood smears. When malignancy is suspected, they conduct bone marrow aspiration and trephine core biopsies. Diagnostic specimens undergo immunophenotyping via flow cytometry, cytogenetic karyotyping, fluorescence in situ hybridisation (FISH), and next-generation sequencing to identify specific gene mutations and chromosomal abnormalities that establish precise diagnoses and guide tailored targeted therapies.

Hematologists care for patients across the entire spectrum of primary blood cancers. Key conditions include acute leukaemias (such as AML and ALL), chronic leukaemias (including CLL and CML), and plasma cell disorders like multiple myeloma and AL amyloidosis. They manage both Hodgkin lymphoma and diverse non-Hodgkin lymphomas, as well as myelodysplastic syndromes, myelofibrosis, polycythaemia vera, and essential thrombocythaemia, coordinating specialised care pathways tailored to each specific haematological disease.

Hematologists direct systemic and cellular treatments. They prescribe conventional chemotherapy, monoclonal antibodies, and targeted inhibitors (such as tyrosine kinase or Bruton tyrosine kinase inhibitors). For complex malignancies, they oversee autologous or allogeneic haematopoietic stem cell transplants and innovative CAR T-cell therapies. They also administer essential supportive measures, including therapeutic blood transfusions, anticoagulant therapies for thrombosis, and prophylactic antimicrobials to safeguard immunocompromised patients against severe systemic infections.